JP Stock MarketDetailed Quotes

4579 RaQualia Pharma

Watchlist
  • 366
  • -3-0.81%
20min DelayNot Open Dec 24 15:30 JST
7.99BMarket Cap-24.43P/E (Static)

RaQualia Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
18.47%762.47M
75.06%648.58M
-34.85%1.9B
-59.98%405.71M
5.31%481.41M
-41.91%643.59M
9.20%370.49M
5.11%2.92B
-12.09%1.01B
51.13%457.12M
Cost of revenue
164.84%166.45M
1.86%60.53M
5.82%245.05M
-12.53%55.63M
5.95%67.14M
22.29%62.85M
11.67%59.43M
-27.78%231.59M
22.91%63.6M
-32.66%63.37M
Gross profit
2.63%596.02M
89.04%588.05M
-38.35%1.66B
-63.16%350.08M
5.21%414.27M
-45.03%580.74M
8.74%311.07M
9.40%2.69B
-13.73%950.13M
88.98%393.75M
Operating expense
60.46%794.74M
29.45%543.53M
9.52%1.99B
-0.98%579.37M
12.39%498.97M
28.57%495.29M
3.44%419.89M
4.15%1.82B
16.87%585.12M
6.68%443.96M
Selling and administrative expenses
100.29%321.09M
21.78%184.52M
8.65%620.95M
-20.00%141.24M
26.97%167.88M
32.91%160.31M
6.59%151.53M
-7.86%571.54M
14.77%176.55M
0.07%132.22M
-General and administrative expense
100.29%321.09M
21.78%184.52M
8.65%620.95M
-20.00%141.24M
26.97%167.88M
32.91%160.31M
6.59%151.53M
-7.86%571.54M
14.77%176.55M
0.07%132.22M
Research and development costs
41.40%473.65M
33.78%359.01M
9.92%1.37B
7.23%438.13M
6.21%331.1M
26.59%334.98M
1.75%268.36M
10.76%1.25B
17.80%408.58M
9.76%311.74M
Operating profit
-332.56%-198.72M
140.91%44.52M
-138.95%-337.37M
-162.82%-229.29M
-68.71%-84.71M
-87.27%85.45M
9.20%-108.82M
22.37%866.24M
-39.23%365.01M
75.84%-50.21M
Net non-operating interest income (expenses)
-6,189.05%-13.21M
148.87%1.75M
88.00%-988K
113.14%2.08M
439.39%712K
-107.15%-210K
-178.60%-3.57M
-138.71%-8.24M
-430.64%-15.85M
-97.83%132K
Non-operating interest income
-51.65%776K
142.98%3.81M
-28.98%9.7M
180.48%4.21M
27.83%2.32M
-68.02%1.61M
-70.56%1.57M
-40.23%13.66M
-71.91%1.5M
-71.90%1.81M
Non-operating interest expense
814.41%13.9M
29.08%1.94M
11.44%6.68M
17.80%2.05M
-4.53%1.6M
-18.72%1.52M
113.92%1.51M
312.31%6M
217.30%1.74M
599.58%1.68M
Total other finance cost
-71.53%84K
-96.70%120K
-74.81%4.01M
-99.52%75K
--0
39.81%295K
4,682.89%3.64M
13,147.50%15.9M
--15.61M
--0
Net investment income
-61.06%32.66M
557.60%42.03M
19.09%52.04M
57.02%-59.64M
101.57%21.41M
-23.54%83.87M
-89.72%6.39M
-70.01%43.7M
-853.17%-138.76M
-37.99%10.62M
Gain(Loss) on financial instruments designated as cash flow hedges
14.36%-25.25M
-209.47%-26.53M
-283.26%-25.06M
5.53%21.71M
-123.50%-8.71M
3.45%-29.48M
36.22%-8.57M
235.65%13.67M
1,659.36%20.57M
37.07M
Gain(Loss) on derecognition of available-for-sale financial assets
172.73%600K
-52.01%2.53M
105.91%2.74M
100.23%130K
-503.22%-2.88M
-97.75%220K
2,119.16%5.27M
-377.85%-46.35M
-508.60%-56.6M
-25.39%714K
Income from associates and other participating interests
Special income (charges)
0
0
-17.8M
0
0
Less:Other special charges
----
----
----
----
----
----
----
--17.8M
--0
--0
Other non-operating income (expenses)
-36.94%4.34M
-19,155.91%-138.45M
7,011.37%14.58M
131.69%8.07M
120.70%348K
578.91%6.88M
-24.61%-719K
75.12%-211K
2,222.67%3.48M
-5,353.13%-1.68M
Income before tax
-236.01%-199.58M
32.60%-74.16M
-134.55%-294.05M
-244.47%-256.94M
-2,103.19%-73.83M
-80.74%146.74M
-29.09%-110.02M
-3.36%851.01M
-72.06%177.85M
98.26%-3.35M
Income tax
270.30%46.18M
-89.70%3.95M
-76.80%29.61M
35.03%-50.91M
6,853.31%69.29M
-115.83%-27.12M
7.51%38.35M
2.27%127.62M
-256.33%-78.37M
98.26%-1.03M
Net income
-241.36%-245.75M
47.36%-78.11M
-144.74%-323.66M
-180.41%-206.03M
-6,052.97%-143.12M
-70.55%173.85M
-22.72%-148.37M
-4.29%723.39M
-56.31%256.22M
98.26%-2.33M
Net income continuous operations
-241.36%-245.75M
47.36%-78.11M
-144.74%-323.66M
-180.41%-206.02M
-6,055.61%-143.12M
-70.55%173.85M
-22.72%-148.37M
-4.29%723.39M
-56.31%256.22M
98.26%-2.33M
Noncontrolling interests
0
0
0
Net income attributable to the company
-241.36%-245.75M
47.36%-78.11M
-144.74%-323.66M
-180.41%-206.03M
-6,052.97%-143.12M
-70.55%173.85M
-22.72%-148.37M
-4.29%723.39M
-56.31%256.22M
98.26%-2.33M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-241.36%-245.75M
47.36%-78.11M
-144.74%-323.66M
-180.41%-206.03M
-6,052.97%-143.12M
-70.55%173.85M
-22.72%-148.37M
-4.29%723.39M
-56.31%256.22M
98.26%-2.33M
Gross dividend payment
Basic earnings per share
-240.94%-11.36
47.53%-3.61
-143.42%-14.98
-177.99%-9.53
-5,425.00%-6.63
-71.39%8.06
-19.24%-6.88
-4.35%34.5
-56.34%12.22
98.12%-0.12
Diluted earnings per share
-241.25%-11.36
47.53%-3.61
-143.46%-14.98
-178.11%-9.53
-5,425.00%-6.63
-71.43%8.0426
-19.24%-6.88
-4.36%34.47
-56.38%12.2
98.12%-0.12
Dividend per share
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 18.47%762.47M75.06%648.58M-34.85%1.9B-59.98%405.71M5.31%481.41M-41.91%643.59M9.20%370.49M5.11%2.92B-12.09%1.01B51.13%457.12M
Cost of revenue 164.84%166.45M1.86%60.53M5.82%245.05M-12.53%55.63M5.95%67.14M22.29%62.85M11.67%59.43M-27.78%231.59M22.91%63.6M-32.66%63.37M
Gross profit 2.63%596.02M89.04%588.05M-38.35%1.66B-63.16%350.08M5.21%414.27M-45.03%580.74M8.74%311.07M9.40%2.69B-13.73%950.13M88.98%393.75M
Operating expense 60.46%794.74M29.45%543.53M9.52%1.99B-0.98%579.37M12.39%498.97M28.57%495.29M3.44%419.89M4.15%1.82B16.87%585.12M6.68%443.96M
Selling and administrative expenses 100.29%321.09M21.78%184.52M8.65%620.95M-20.00%141.24M26.97%167.88M32.91%160.31M6.59%151.53M-7.86%571.54M14.77%176.55M0.07%132.22M
-General and administrative expense 100.29%321.09M21.78%184.52M8.65%620.95M-20.00%141.24M26.97%167.88M32.91%160.31M6.59%151.53M-7.86%571.54M14.77%176.55M0.07%132.22M
Research and development costs 41.40%473.65M33.78%359.01M9.92%1.37B7.23%438.13M6.21%331.1M26.59%334.98M1.75%268.36M10.76%1.25B17.80%408.58M9.76%311.74M
Operating profit -332.56%-198.72M140.91%44.52M-138.95%-337.37M-162.82%-229.29M-68.71%-84.71M-87.27%85.45M9.20%-108.82M22.37%866.24M-39.23%365.01M75.84%-50.21M
Net non-operating interest income (expenses) -6,189.05%-13.21M148.87%1.75M88.00%-988K113.14%2.08M439.39%712K-107.15%-210K-178.60%-3.57M-138.71%-8.24M-430.64%-15.85M-97.83%132K
Non-operating interest income -51.65%776K142.98%3.81M-28.98%9.7M180.48%4.21M27.83%2.32M-68.02%1.61M-70.56%1.57M-40.23%13.66M-71.91%1.5M-71.90%1.81M
Non-operating interest expense 814.41%13.9M29.08%1.94M11.44%6.68M17.80%2.05M-4.53%1.6M-18.72%1.52M113.92%1.51M312.31%6M217.30%1.74M599.58%1.68M
Total other finance cost -71.53%84K-96.70%120K-74.81%4.01M-99.52%75K--039.81%295K4,682.89%3.64M13,147.50%15.9M--15.61M--0
Net investment income -61.06%32.66M557.60%42.03M19.09%52.04M57.02%-59.64M101.57%21.41M-23.54%83.87M-89.72%6.39M-70.01%43.7M-853.17%-138.76M-37.99%10.62M
Gain(Loss) on financial instruments designated as cash flow hedges 14.36%-25.25M-209.47%-26.53M-283.26%-25.06M5.53%21.71M-123.50%-8.71M3.45%-29.48M36.22%-8.57M235.65%13.67M1,659.36%20.57M37.07M
Gain(Loss) on derecognition of available-for-sale financial assets 172.73%600K-52.01%2.53M105.91%2.74M100.23%130K-503.22%-2.88M-97.75%220K2,119.16%5.27M-377.85%-46.35M-508.60%-56.6M-25.39%714K
Income from associates and other participating interests
Special income (charges) 00-17.8M00
Less:Other special charges ------------------------------17.8M--0--0
Other non-operating income (expenses) -36.94%4.34M-19,155.91%-138.45M7,011.37%14.58M131.69%8.07M120.70%348K578.91%6.88M-24.61%-719K75.12%-211K2,222.67%3.48M-5,353.13%-1.68M
Income before tax -236.01%-199.58M32.60%-74.16M-134.55%-294.05M-244.47%-256.94M-2,103.19%-73.83M-80.74%146.74M-29.09%-110.02M-3.36%851.01M-72.06%177.85M98.26%-3.35M
Income tax 270.30%46.18M-89.70%3.95M-76.80%29.61M35.03%-50.91M6,853.31%69.29M-115.83%-27.12M7.51%38.35M2.27%127.62M-256.33%-78.37M98.26%-1.03M
Net income -241.36%-245.75M47.36%-78.11M-144.74%-323.66M-180.41%-206.03M-6,052.97%-143.12M-70.55%173.85M-22.72%-148.37M-4.29%723.39M-56.31%256.22M98.26%-2.33M
Net income continuous operations -241.36%-245.75M47.36%-78.11M-144.74%-323.66M-180.41%-206.02M-6,055.61%-143.12M-70.55%173.85M-22.72%-148.37M-4.29%723.39M-56.31%256.22M98.26%-2.33M
Noncontrolling interests 000
Net income attributable to the company -241.36%-245.75M47.36%-78.11M-144.74%-323.66M-180.41%-206.03M-6,052.97%-143.12M-70.55%173.85M-22.72%-148.37M-4.29%723.39M-56.31%256.22M98.26%-2.33M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -241.36%-245.75M47.36%-78.11M-144.74%-323.66M-180.41%-206.03M-6,052.97%-143.12M-70.55%173.85M-22.72%-148.37M-4.29%723.39M-56.31%256.22M98.26%-2.33M
Gross dividend payment
Basic earnings per share -240.94%-11.3647.53%-3.61-143.42%-14.98-177.99%-9.53-5,425.00%-6.63-71.39%8.06-19.24%-6.88-4.35%34.5-56.34%12.2298.12%-0.12
Diluted earnings per share -241.25%-11.3647.53%-3.61-143.46%-14.98-178.11%-9.53-5,425.00%-6.63-71.43%8.0426-19.24%-6.88-4.36%34.47-56.38%12.298.12%-0.12
Dividend per share
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Axel Mark
3624
129 +30.30%
DREAM VISION
3185
232 +27.47%
MarketEnterprise
3135
1411 +26.66%
Beauty Kadan Holdings
3041
440 +22.22%
Seed
7743
635 +18.69%

See the daily top gainer.